# Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/addition-of-bevacizumab-to-erlotinib-as-first-line-treatment-of-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Maria Carmela Piccirillo,Laura Bonanno,Marina Chiara Garassino,Giovanna Esposito,Claudio Dazzi,Luigi Cavanna,Marco Angelo Burgio,Francesco Rosetti,Simona Rizzato,Floriana Morgillo,Saverio Cinieri,Antonello Veccia,Maximilan Papi,Giuseppe Tonini,Vittorio Gebbia,Serena Ricciardi,Daniele Pozzessere,Alessandra Ferro,Claudia Proto,Raffaele Costanzo,M. D’Arcangelo,Manuela Proietto,Piera Gargiulo,Raimondo Di Liello,Laura Arenare,Filippo de Marinis,Lucio Crinò,Fortunato Ciardiello,Nicola Normanno,Ciro Gallo,Francesco Perrone,Cesare Gridelli,Alessandro Morabito |
| Citations | 69 |
| DOI | 10.1016/j.jtho.2022.05.008 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.jtho.2022.05.008 |
| OpenAlex ID | https://openalex.org/W4281765847 |
| PMID | 35659580 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Serena Ricciardi](https://scholariq.org/researchers/serena-ricciardi/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.